Economic Evaluations

Handling missing values in individual-level cost-effectiveness analyses

Invited presentation

Joint longitudinal models for dealing with missing at random data in trial-based economic evaluations

Objectives: In trial-based economic evaluation, some individuals are typically associated with missing data at some time point, so that their corresponding aggregated outcomes (eg, quality-adjusted life-years) cannot be evaluated. Restricting the …

Linear mixed models to handle missing at random data in trial-based economic evaluations

Contributed presentation

A Bayesian framework for patient-level partitioned survival cost-utility analysis

Patient-level health economic data collected alongside clinical trials are an important component of the process of technology appraisal, with a view to informing resource allocation decisions. For end of life treatments, such as cancer treatments, …

Understanding Health Economics in Clinical Trials

Three day short course"

Joint longitudinal models for dealing with missing at random data in trial-based economic evaluations

Health economic evaluations based on patient-level data collected alongside clinical trials (e.g. health related quality of life and resource use measures) are an important component of the process which informs resource allocation decisions. Almost …

Addition of abiraterone to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Model to estimate long-term survival, quality-adjusted survival, and cost-effectiveness

Results from randomised trials show adding abiraterone acetate plus prednisolone (AAP) to standard of care (SOC) improves disease-free and overall survival in men with prostate cancer (PC) starting long-term hormone therapy for first time. Formal …

Understanding Health Economics in Clinical Trials

One day short course

Choosing the Missing Data Method in Trial-Based Economic Evaluations. How to Make the Right Choice?

Invited presentation

A Bayesian Parametric Approach to Handle Missing Longitudinal Outcome Data in Trial-Based Health Economic Evaluations

Contibuted poster